granisetron has been researched along with Thoracic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Fujita, Y; Funaguchi, N; Gomyo, T; Hakamata, J; Hirose, C; Iihara, H; Ikemura, S; Imai, H; Kaito, D; Kawazoe, H; Kotake, M; Minato, K; Ohno, Y; Okura, H; Sakai, C; Shimokawa, M; Suzuki, A | 1 |
1 trial(s) available for granisetron and Thoracic Neoplasms
| Article | Year |
|---|---|
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Topics: Carboplatin; Dexamethasone; Granisetron; Humans; Japan; Nausea; Olanzapine; Prospective Studies; Thoracic Neoplasms; Vomiting | 2021 |